Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2). (4th November 2015)

• Record Type: Journal Article
• Authors: Erbe, Amy K; Wang, Wei; Kim, Kyung Mann; Carmichael, Laskeesha; Gallendberger, MIkayla; Hess, Dustin; Mendonca, Eneida A; Song, Yiqiang; Hank, Jacquelyn A; Chen, Su-Chun; Signoretti, Sabina; Atkins, Michael B; Carlson, Alexander; Mier, James; Panka, David; McDermott, David F; Sondel, Paul M
• Is Part Of: Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
• Publication Date: 2015-11-04
• Subjects: Renal Cell Carcinoma -- Metastatic Renal Cell Carcinoma -- Tumor Shrinkage -- Exploratory Finding -- Dual Combination; Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1186/2051-1426-3-S2-P300
• Languages: English
• ISSNs: 2051-1426